Literature DB >> 8712227

Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.

S J Goldie1, L Kiernan-Tridle, C Torres, N Gorban-Brennan, D Dunne, A S Kliger, F O Finkelstein.   

Abstract

Fungal peritonitis (FP) is a rare but serious complication of chronic peritoneal dialysis (CPD) therapy and is associated with high morbidity and CPD drop-out. Risk factors and management of FP remain controversial. We reviewed our experience with FP in an attempt to identify risk factors and to examine outcome in relation to treatment strategies. Between March 1984 and August 1994, 704 patients were maintained on CPD therapy in our unit. A total of 1,712 episodes of peritonitis were identified among these patients. Fungal peritonitis accounted for 55 (3.2%) of these episodes. The patients on CPD therapy who developed FP were similar to those who did not develop FP with regard to age, gender, underlying etiology for end-stage renal disease, and comorbid disease. Prior antibiotic use was noted in 87.3% of episodes of FP. The peritonitis rate in the patients who developed FP was one episode every 5.1 months compared with one episode every 9.9 patient-months in the CPD patients who did not develop this infection. Candida sp caused 74.5% of the episodes of FP. All patients were treated with antifungal drugs. In 85.5% of infections the Tenckhoff catheter was removed within 1 week of the diagnosis of FP; 31.9% of the patients who had the Tenckhoff catheter removed did not have the catheter replaced because of death or transfer to hemodialysis. In the patients who developed FP, 68.1% had the Tenckhoff catheter replaced; of these patients, 90.6% and 59.4% were on CPD therapy 1 and 6 months after catheter replacement, respectively. We conclude that risk factors identified in our population include peritonitis rate and prior antibiotic use. Fungal peritonitis is rare in our CPD population, and although it leads to significant CPD drop-out, it can be managed in many patients with antifungal therapy, early catheter removal, and temporary hemodialysis. Of the catheters replaced between 2 and 8 weeks after the diagnosis of FP, 91% functioned successfully, allowing continuation of CPD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712227     DOI: 10.1016/s0272-6386(96)90135-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  27 in total

1.  Fungal peritonitis in the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.

Authors:  Raj Munshi; Christine B Sethna; Troy Richardson; Jonathan Rodean; Samhar Al-Akash; Sushil Gupta; Alicia M Neu; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2018-01-08       Impact factor: 3.714

Review 2.  Fungal peritonitis in children on peritoneal dialysis.

Authors:  Renske Raaijmakers; Cornelis Schröder; Leo Monnens; Elisabeth Cornelissen; Adilla Warris
Journal:  Pediatr Nephrol       Date:  2006-11-17       Impact factor: 3.714

3.  Oral care practices in intensive care units: a survey of 59 European ICUs.

Authors:  Jordi Rello; Despoina Koulenti; Stijn Blot; Rafael Sierra; Emili Diaz; Jan J De Waele; Antonio Macor; Kemal Agbaht; Alejandro Rodriguez
Journal:  Intensive Care Med       Date:  2007-03-24       Impact factor: 17.440

4.  Factors Associated With Increased Hospital Length of Stay in Peritoneal Dialysis Patients With Peritonitis: A Need for Antimicrobial Stewardship?

Authors:  Taylor Morrisette; Robert B Canada; Danielle Padgett; Joanna Q Hudson
Journal:  Hosp Pharm       Date:  2018-12-07

5.  The promising future of long-term peritoneal dialysis.

Authors:  Dimitrios Oreopoulos; Elias Thodis; Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

6.  32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

Authors:  Sadie van Esch; Raymond T Krediet; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 7.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 8.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Candida parapsilosis peritonitis in patients on CAPD.

Authors:  Charoen Kaitwatcharachai
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

Review 10.  Dialysis-associated peritonitis in children.

Authors:  Vimal Chadha; Franz S Schaefer; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2009-02-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.